Yulon Finance Corporation (TPE:9941)

bluebird bio Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	17,824	17,623	15,450	13,525	12,998	12,944
Other Revenue	22,949	23,848	26,039	23,031	18,964	16,689
Revenue	40,773	41,471	41,489	36,557	31,962	29,633
Revenue Growth (YoY)	-3.16%	-0.04%	13.49%	14.37%	7.86%	1.65%
Cost of Revenue	21,609	21,334	18,811	15,405	14,490	14,884
Gross Profit	19,164	20,138	22,679	21,151	17,472	14,749
Selling, General & Admin	5,262	5,163	4,789	4,344	3,593	2,921
Other Operating Expenses	1,488	1,482	1,424	1,281	1,084	1,218
Operating Expenses	13,257	13,844	14,841	12,263	10,657	11,178
Operating Income	5,907	6,294	7,838	8,888	6,815	3,571
Interest Expense	-68.92	-52.72	-38.61	-14.04	-12.35	-36.43
Earnings From Equity Investments	152.85	139.66	194.21	-907.21	24.85	19.59
Currency Exchange Gain (Loss)	-36.45	-37.9	-15.53	0.57	0.63	3.13
Other Non Operating Income (Expenses)	457.25	406.15	478.16	310.88	203.14	145.62
EBT Excluding Unusual Items	6,412	6,749	8,456	8,278	7,032	3,703
Gain (Loss) on Sale of Investments	-38.73	-109.87	2.22	11.15	0	0.09
Gain (Loss) on Sale of Assets	316.94	317.18	-3.23	-0.06	-7.76	3.33
Asset Writedown	2.47	2.47	0.84	-	-	-
Other Unusual Items	-25.38	-25.38	-29.67	-	-	-
Pretax Income	6,667	6,933	8,426	8,290	7,024	3,707
Income Tax Expense	1,774	1,840	2,023	2,161	1,664	809.4
Earnings From Continuing Operations	4,893	5,093	6,403	6,128	5,360	2,897
Minority Interest in Earnings	51.62	9.3	-128.94	-324.44	-206.02	242.05
Net Income	4,945	5,102	6,275	5,804	5,154	3,139
Preferred Dividends & Other Adjustments	233.46	233.94	207.07	200	200	200
Net Income to Common	4,711	4,869	6,067	5,604	4,954	2,939
Net Income Growth	-14.54%	-18.68%	8.11%	12.62%	64.17%	5.97%
Shares Outstanding (Basic)	548	548	548	511	492	492
Shares Outstanding (Diluted)	600	589	548	511	492	492
Shares Change (YoY)	9.32%	7.51%	7.20%	3.94%	-0.03%	-0.01%
EPS (Basic)	8.59	8.88	11.07	10.96	10.07	5.98
EPS (Diluted)	8.22	8.60	11.07	10.96	10.06	5.98
EPS Growth	-19.06%	-22.30%	1.00%	8.91%	68.43%	6.68%
Free Cash Flow	12,448	11,865	-14,500	-31,382	-23,955	789.93
Free Cash Flow Per Share	20.76	20.13	-26.45	-61.36	-48.68	1.60
Dividend Per Share	4.380	4.380	6.100	5.091	4.274	3.176
Dividend Growth	-28.20%	-28.20%	19.82%	19.13%	34.57%	14.89%
Gross Margin	47.00%	48.56%	54.66%	57.86%	54.67%	49.77%
Operating Margin	14.49%	15.18%	18.89%	24.31%	21.32%	12.05%
Profit Margin	11.55%	11.74%	14.62%	15.33%	15.50%	9.92%
Free Cash Flow Margin	30.53%	28.61%	-34.95%	-85.84%	-74.95%	2.67%
EBITDA	6,354	6,569	8,034	9,030	6,987	3,795
EBITDA Margin	15.58%	15.84%	19.36%	24.70%	21.86%	12.81%
D&A For EBITDA	446.24	275.3	196.26	141.63	171.52	224.1
EBIT	5,907	6,294	7,838	8,888	6,815	3,571
EBIT Margin	14.49%	15.18%	18.89%	24.31%	21.32%	12.05%
Effective Tax Rate	26.61%	26.54%	24.01%	26.07%	23.69%	21.84%
Revenue as Reported	40,773	41,471	41,489	36,557	31,962	29,633

Source: S&P Global Market Intelligence. Standard template. Financial Sources.